–(BUSINESS WIRE)–ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.
|
Company: |
ReAlta Life Sciences, Inc. |
|
|
|
|
|
|
Headquarters Address: |
4211 Monarch Way |
|
|
|
Suite 102 |
|
|
|
Norfolk, VA 23508 |
|
|
|
|
|
|
Main Telephone: |
757-901-0460 |
|
|
|
|
|
|
Website: |
||
|
|
|
|
|
Type of Organization: |
Private |
|
|
|
|
|
|
Industry: |
Pharmaceutical |
|
|
|
|
|
|
Key Executives: |
CEO: Ulrich Thienel, MD, PhD |
|
|
|
Chief Medical Officer: Kenji Cunnion, MD, MPH |
|
|
|
Chief Science Officer: Neel Krishna, PhD |
|
|
|
|
|
|
Investor Relations |
|
|
|
Contact: |
Ulrich Thienel, MD, PhD |
|
|
Phone: |
(757) 901-0460 |
|
|
Email: |
